PMV Pharmaceuticals's total assets for Q4 2025 were $116.56M, a decrease of -12.91% from the previous quarter. PMVP total liabilities were $11.85M for the fiscal quarter, a -7.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.